These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1037366)

  • 21. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
    Jensen AØ; Thomsen HF; Engebjerg MC; Olesen AB; Friis S; Karagas MR; Sørensen HT
    Br J Cancer; 2009 Jan; 100(1):200-5. PubMed ID: 19034275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.
    Lewis FB; Schwartz RS; Dameshek W
    Clin Exp Immunol; 1966 Jan; 1(1):3-11. PubMed ID: 5953036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC).
    Guo HR; Yu HS; Hu H; Monson RR
    Cancer Causes Control; 2001 Dec; 12(10):909-16. PubMed ID: 11808710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma.
    Berg JW
    J Natl Cancer Inst; 1967 May; 38(5):741-52. PubMed ID: 5229351
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous malignancy related to cyclosporin A therapy.
    Green C; Hawk JL
    Clin Exp Dermatol; 1993 Jan; 18(1):30-1. PubMed ID: 8440049
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
    Molin L; Larkö O
    Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
    [No Abstract]   [Full Text] [Related]  

  • 28. Midwest cooperative group evaluation of piposulfan (A-20968) in cancer.
    Nelson NA; Talley RW; Reed ML; Evans AM; Isaacs BL; Huffman P; Louis J
    Clin Pharmacol Ther; 1967; 8(3):385-91. PubMed ID: 5338383
    [No Abstract]   [Full Text] [Related]  

  • 29. Tattoos, inks, and cancer.
    Kluger N; Koljonen V
    Lancet Oncol; 2012 Apr; 13(4):e161-8. PubMed ID: 22469126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Some reflections on the favorable effects of chlorambucil in unusual doses].
    Kissel P; Debry G; Royer R; Picard L
    Ann Med Nancy; 1965 Dec; 4():1133-5. PubMed ID: 5898202
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma.
    Orouji A; Goerdt S; Utikal J; Leverkus M
    Br J Dermatol; 2014 Aug; 171(2):431-3. PubMed ID: 24446722
    [No Abstract]   [Full Text] [Related]  

  • 32. Arsenical intoxication due to pollution.
    Degreef H; Roelandts R
    Arch Belg Dermatol; 1974; 30(1):35-8. PubMed ID: 4283058
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.
    Praestegaard C; Kjaer SK; Andersson M; Steding-Jensen M; Frederiksen K; Mellemkjaer L
    Breast Cancer; 2016 Nov; 23(6):908-916. PubMed ID: 26660140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
    Nardone B; Orrell KA; Vakharia PP; West DP
    Expert Opin Drug Saf; 2018 Feb; 17(2):139-147. PubMed ID: 29103328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins in dermatology: is nonmelanoma skin cancer the dark side of the moon?
    Mascitelli L; Goldstein MR
    Int J Dermatol; 2013 Jul; 52(7):899-900. PubMed ID: 22512761
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 37. [New formation of malignant tumors during cytostatic therapy. Case report].
    Renner K
    Strahlentherapie; 1971 Sep; 142(3):308-11. PubMed ID: 5118499
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
    Kaufmann B; Wegmann W
    Schweiz Med Wochenschr; 1981 Apr; 111(15):540-5. PubMed ID: 7233132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR; Papazian R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.